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Salmonella has been a model pathogen for examining CD4 T cell activation and effector
functions for many years due to the strength of the Th1 cell response observed during
Salmonella infections, the relative ease of use of Salmonella, the availability of Salmo-
nella-specific T cell reagents, and the well-characterized nature of the model system, the
pathogen, and the immune response elicited. Herein, we discuss the use of Salmonella
as a model pathogen to explore the complex interaction of T cells with their inflammatory
environment. In particular, we address the issue of bystander activation of naïveT cells and
non-cognate stimulation of activated and memoryT cells. Further, we compare and contrast
our current knowledge of these non-cognate responses in CD8 versus CD4T cells. Finally,
we make a case for Salmonella as a particularly appropriate model pathogen in the study
of non-cognate CD4 T cell responses based on the strength of the Th1 response during
infection, the requirement for CD4T cells in bacterial clearance, and the well-characterized
inflammatory response to conserved molecular patterns induced by Salmonella infection.
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INTRODUCTION
T cell activation and effector functions have been extensively stud-
ied in vitro, allowing for controlled interactions within a defined
environment. However, studying T cells in vitro inherently limits
interactions to those that have been previously defined. To explore
more complex systems of interactions beyond known parameters
requires using an in vivo model system. One common technique
for studying T cell responses in vivo is to examine a population of
T cells with known antigen specificity. This includes the use of T
cell receptor (TCR) transgenic mice, model antigens like ovalbu-
min, and major histocompatibility complex (MHC) class I and II
tetramers presenting defined peptide sequences, which allows for
the detection of T cells specifically recognizing that peptide. These
reagents have greatly facilitated the tracking of antigen-specific T
cells and the study of monoclonal T cell responses. Together with
in vitro studies, the examination of antigen-specific T cells in vivo
has been essential in defining much of what we know about T cell
immunology.
When trying to understand the diverse polyclonal responses
that are induced by infections, in vivo techniques that exam-
ine individual antigen-specific responses are likely to be limited.
The natural breadth of the naïve TCR repertoire is an important
strength of the adaptive immune response and can only be main-
tained by having pools of individual clones at very low frequency.
Recent evidence has shown that altering the frequency of a given T
cell clone can impact the activation strength, kinetics, and memory
formation of the resulting T cell response (1–4). This issue compli-
cates TCR transgenic mouse studies, which focus on a monoclonal
population, generally used at unnaturally high frequency. Studying
the natural endogenous precursor population is therefore impor-
tant and also complex since the frequency of individual clones also
varies within the naïve repertoire (5).
Furthermore, individual TCR specificities may be predisposed
toward different fates (6) and may also be regulated by tempo-
ral and anatomical antigen expression by the pathogen, factors
that might significantly affect some clonal populations differently
than the overall polyclonal T cell response (7, 8). These issues
affect the use of TCR transgenic mice, MHC tetramer studies, and
model antigens, because it may lead to a situation where the T
cell response under study may not be representative of the overall
T cell response to the pathogen. Likewise, studies that attempt to
activate T cells with model antigens in the absence of infection are
unlikely to accurately reflect the complex interactions that occur
between T cells and the rest of the immune system in the context
of a strong inflammatory response. Thus, to examine the full range
of T cell functions and interactions within the larger immune net-
work, it is necessary to study them in the context of a natural
polyclonal response that includes a broad range of antigens and
the inflammatory milieu that differentiates infection from other
surrogate means of activation.
When exploring the responses of CD4 T cells, in particular,
it is critical to examine their functions under circumstances in
which they are naturally induced and required. In other words,
it makes very little sense to study the effector function of Th1
cells using models where these Th1 cells do not contribute to
pathogen clearance. The role of the Th1 subset of CD4 T cells
and its effector cytokine IFN-γ in Salmonella infections has been
very well established (9–11), making Salmonella model systems
particularly appropriate for characterizing Th1 cell functions.
Additionally, the innate immune response and inflammatory
responses occurring during Salmonella infections are relatively
well-defined (12–16), making it an ideal model to characterize
the influence of natural inflammatory conditions on these Th1
cell responses.
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In this review, we will highlight the unique advantage of the
Salmonella model system for studying Th1 responses to innate
stimuli. First, in Section “Armed and Ready: T Cell Responses
to Innate Signals,” we discuss and compare conventional cognate
T cell stimulation, non-cognate stimulation of activated conven-
tional T cells, and the responses of innate-like T cells. Thus far,
most studies examining non-cognate T cell responses have focused
on CD8 T cells, primarily in viral infection models. It is likely that
the rules governing non-cognate CD8 T cell responses differ in
certain aspects to those governing non-cognate responses in CD4
T cells. However, comparing these responses in infection mod-
els that generate overall weak CD4 T cell responses due to poor
activation does not allow accurate comparison of the capacity of
the non-cognate CD4 T cell response. In Section “A Complicated
Relationship: The Dynamic Interactions of Salmonella and Th1
Cells,” we discuss the dynamic interaction of Salmonella and the
Th1 response, focusing on the important role of Th1 cells in the
resolution of Salmonella infection, and potential ways that Salmo-
nella might be able to subvert cognate T cell recognition and thus
increase the requirement for non-cognate recognition pathways.
ARMED AND READY: T CELL RESPONSES TO INNATE
SIGNALS
CONVENTIONAL T CELL RESPONSES
Before discussing innate stimulation of T cells, we will first briefly
review initial T cell activation, differentiation, secondary stimula-
tion at sites of infection, and formation of memory. Both CD4 and
CD8 T cells are activated upon recognition of a specific peptide
sequence in host MHC by the TCR. CD8 T cells recognize this
peptide presented within MHC-I expressed on most cell surfaces,
while CD4 T cells interact with antigen presented in MHC-II only
by antigen presenting cells (APCs). These APCs, often dendritic
cells (DCs), collect and process antigen in the periphery and return
to the lymph nodes and other secondary lymphoid organs with
the antigens presented on their surface, where they can be recog-
nized by interacting T cells. This first antigen-specific interaction
is referred to as signal 1 of T cell activation (Figure 1) because,
although it is required, the TCR stimulation alone is not sufficient
to functionally activate the T cell. On its own this TCR interac-
tion will ultimately lead to anergy, a state of unresponsiveness that
maintains peripheral tolerance.
During the initial TCR:MHC interaction, the T cell requires
a second signal for the priming process. This second signal is
referred to as costimulation (Figure 1), and can be achieved by a
number of different interactions, although the most common acti-
vating signal is between CD28 on CD4 T cells and B7 molecules on
DCs. The expression of these costimulatory molecules are upregu-
lated on DCs after DC activation by inflammation, increasing the
likelihood that T cells will be activated only when the antigen is
encountered by the DC under appropriate conditions. While this
second signal prevents anergy, a third signal is required to complete
CD4 T cell priming and instruct the differentiation pathway.
Differentiation is a critical step in CD4 T cell priming because
of the eclectic capacities of CD4 T cells. Once a CD4 T cell has
recognized antigen presented by MHC-II and a costimulation sig-
nal, a third cytokine signal (Figure 1) will instruct the CD4 T cell
to differentiate into a subset trained for a particular function. In
FIGURE 1 | Priming of CD4T cells requires three signals. Conventional
activation of naïve CD4 T cells requires three distinct signals. Signal 1: the
TCR (T cell receptor) on the T cell must recognize a particular peptide
sequence, processed within an APC (antigen presenting cell) and
presented by MHC-II (major histocompatibility complex-II) in mice. The CD4
co-receptor shown stabilizes the T cell interaction with MHC-II. Signal 2:
activated DCs (dendritic cells) upregulate the costimulatory molecules B7.1
and B7.2 (also called CD80 and CD86). CD28 on T cells recognize these
costimulatory molecules as a second signal for activation. In the absence of
costimulation T cells undergo anergy or death. Signal 3: the cytokine
environment instructs the final stage of T cell priming by determining the
differentiation pathway undergone by the activated T cell.
this review, we focus on the Th1 subset of CD4 T cells, in which
interleukin-12 (IL-12) allows sustained upregulation of the tran-
scription factor T-bet and, upon re-stimulation, production of
effector cytokines such as IFN-γ, TNFα, and IL-2. Additional CD4
subsets include Th2 (which respond to IL-4 and are regulated by
GATA3),Th17 (combinations of TGF-β, IL-6, IL-21,and IL-23 lead
to RORγt expression), Tfh (T follicular helper, respond to IL-6 and
IL-21 to upregulate Bcl-6), and iTreg cells (induced T regulatory,
TGF-β and IL-2 lead to expression of Foxp3), as well as other, less
well-characterized subsets of CD4 T cells. It is important to note,
however, that substantial evidence now supports the imperma-
nence of some of these differentiation pathways, a concept known
as effector plasticity. Thus, while CD4 T cells require these ini-
tial differentiation instructions, they often retain the capacity to
acquire new functions under sufficient alternative stimulation.
The initial process of T cell activation dramatically alters the
cell, causing upregulation of cascades of transcription factors,
as well as altering the miRNA regulation, epigenetic modifica-
tions, and post-translational pathways. These changes program
the cell with the capacity to rapidly respond upon re-stimulation
in a specialized manner. However, the actual secretion of effec-
tor cytokines still requires some regulation to prevent unnecessary
inflammation. For this reason, activated T cells arrive at sites of
infection primed for rapid response, but not constitutively secret-
ing cytokines. Traditionally, the secondary interactions of activated
T cells at sites of infection are believed to consist of additional
antigen-dependent interactions of the TCR and peptide-MHC
Frontiers in Immunology | Microbial Immunology December 2014 | Volume 5 | Article 621 | 2
O’Donnell and McSorley Non-cognate CD4 response in Salmonella
complexes, which triggers a transient robust effector response in
the appropriate location (17). Unlike the initial activation process,
antigen-specific interaction alone is sufficient to induce cytokine
production, because of the T cell’s activated state (18). However,
much of this work has been conducted in low-inflammatory con-
ditions and focused on the requirement for TCR interactions.
Such work does not rule out a role for inflammatory stimulation
of T cells during infections. Indeed, the ability of inflammatory
cytokines to either activate naïve T cells or stimulate cytokine
secretion from effector T cells will be discussed in the next section.
After initial activation, T cells undergo massive clonal expan-
sion. This expansion of specific effector Th1 cells typically takes
a few days, and in prolonged infections like Salmonella this T
cell response can take a few weeks to reach the peak of expan-
sion. During this time, T cells are responding to a complex
network of signals, including IL-7 to survive, IL-2 to prolifer-
ate, pro-inflammatory cytokines, anti-inflammatory cytokines,
and potentially secondary TCR signals. The combination of these
encounters does more than just stimulate T cells to produce effec-
tor cytokines – it establishes their fate. While T cell responses are
critical to pathogen clearance in many cases, they also have the
potential to damage host tissues and for this reason, most T cells
will ultimately be instructed to die. Thus, after the peak of clonal
expansion T cells undergo a contraction phase in which most T
cells receive apoptotic signals and are removed from circulation.
However, some T cells receive just the right combination of
stimuli and survival signals to transition from an “armed and
ready” effector state to a quiescent memory state. CD4 T cells
can exist in a number of different memory states, which may ulti-
mately affect their longevity, the areas in which they circulate, and
the requirements for re-activation. The best described examples
of CD4 memory subsets are the central versus effector memory T
cells, which circulate in lymphoid tissue or non-lymphoid tissue,
respectively. CD8 T cells are also believed to form these subsets,
as well as memory populations called short-lived effector cells
(SLECs) or memory precursor effector cells (MPECs) whose for-
mation depends heavily on the inflammatory signals received, but
which have not been described for CD4 T cells. Memory T cells
are an important component of the rapid response to re-challenge
with previously encountered pathogens because of their lowered
activation threshold, pre-differentiated state, and extensive epige-
netic modifications that allow for rapid relay of the signals needed
to elicit effector function. Understanding how these memory T
cells are formed and are able to respond is especially crucial to
vaccine design.
While the above mechanisms comprise a very basic understand-
ing of conventional T cell activation, there are a number of caveats
and exceptions that are worth discussing. In Section “Bystander
Activation and Non-Cognate Stimulation,”we will discuss the abil-
ity of T cells to respond to non-TCR stimuli, focusing on what
has been referred to in the literature alternatively as bystander
activation or non-cognate stimulation. A partial mechanism for
non-cognate stimulation of Th1 cells is illustrated in Figure 2.
In Section “Innate-Like T Cells and ILCs,” we will outline some
of the non-conventional T cell subsets that are able to respond
to non-cognate stimuli to draw parallels between these “innate-
like” cell types and the innate-like functions of classically activated
FIGURE 2 | Partial mechanism for non-cognate stimulation of activated
CD4T cells. (A) Initiation of innate and adaptive immune responses during
intracellular infections. CD4 T cells are initially activated in lymph tissues
upon recognition of particular peptide antigens presented by antigen
presenting cells (APCs). During intracellular infections, the presence of
IFN-γ and IL-12 results in differentiation of these activated CD4 T cells into
Th1 cells, which produce IFN-γ. The Th1 cells then traffic to sites of
infection, where they require additional stimulation to induce production of
effector cytokines. Meanwhile, sites of infection experience inflammation
elicited by innate recognition of pathogens. Pattern recognition receptors
such as toll-like receptors (TLRs) and nod-like receptors (NLRs) recognize
conserved products of infection, called microbe-associated molecular
patterns (MAMPs). (B) Innate inflammation stimulates Th1 cells to amplify
effector response at sites of infection. TLR recognition of innate ligands
results in the upregulation of pro-IL-18, while NLR recognition of infection
activates caspase-1. Caspase-1 cleavage of pro-IL-18 into the mature form of
the cytokine IL-18 allows secretion. IL-18 receptor is required by Th1 cells for
non-cognate elicitation of IFN-γ. CD4 T cell stimulation at sites of infection
likely involves additional cytokine pathways, including IL-12, which can act
synergistically with IL-18 to stimulate Th1 cells.
T cells. Figure 3 compares the interactions that occur in each
of these cell responses and highlights areas that require further
elaboration.
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FIGURE 3 | Elicitation of CD4 and “innate-like”T cell effector functions.
T cell effector functions can result from interactions with APCs or cytokines
at various stages. In the conventional T cell response (first column, blue),
naïve T cells are activated by direct interactions with APCs in the secondary
lymphoid tissues, proliferate, migrate to sites of infection, and then are
stimulated by secondary direct APC contact to produce effector cytokines.
Some of these effector T cells will go on to become memory T cells. T
central memory (TCM) cells circulate in secondary lymphoid tissues, and
upon re-activation will once again proliferate and differentiate into effector
cells. T effector memory (TEM) cells can either migrate in the periphery or be
resident in tissue, and respond more rapidly than the TCM cells because
upon re-activation they can secrete effector cytokines directly. The signals
that result in the TEM or TCM fate decision are still unclear, as are the
interactions required by each for re-activation, although it is presumed that
re-activation occurs after direct interaction with an APC. Non-cognate
stimulation (second column, indigo) occurs at sites of infection in T cells
that have already undergone conventional activation in the secondary
lymphoid tissues. Instead of being stimulated by secondary direct APC
contact, these cells receive stimulatory signals from cytokines that induce
IFN-γ production. Whether these cells go on to join the memory pool and
how this different stimulation signal affects the fate decision of CD4 T cells
is unknown. Bystander activation is a term that has been used loosely to
mean any TCR-independent T cell stimulatory interaction. In the third
column (purple), we focus on the idea of bystander activation as a
mechanism to prime a CD4 T cell in a TCR-independent manner. While the
effect of cytokines on naïve T cells have been studied at length in vitro,
there is limited evidence that a naïve CD4 T cell can be activated by
cytokine signals alone, and no evidence that TCR-independent activation
(Continued )
FIGURE 3 | Continued
can produce a fully functional effector T cell. The last column (pink) provides
a general representation of innate-like T cell subsets. Although the initial
priming signals for the different innate-like T cell populations vary and are
still unclear in some cases, they include alternative activation mechanisms
such as restricted TCRs or constitutive priming. Stimulation of effector
responses at sites of infection in innate-like T cells is known to occur rapidly
in response to cytokine stimulation, hence the name “innate-like” T cells.
However, it is possible that all T cells have the capacity, once activated, to
respond rapidly to cytokine stimulation, and that what really separates
these innate-like cell types are their unique priming mechanisms.
BYSTANDER ACTIVATION AND NON-COGNATE STIMULATION
The strict processes governing conventional T cell activation are
important to avoid the uncontrolled activation of effector T cell
responses. However, under some circumstances, such as during a
rapidly dividing or systemic infection, these may become a hin-
drance to achieving the necessary strength and rapidity of the
effector response. Thus, non-cognate stimulation of conventional
T cells has been described in a number of model systems. Non-
cognate interactions are defined negatively as any stimuli without
TCR recognition of cognate peptide-MHC complexes presented
on APCs. This type of T cell activation has often been referred to
as “bystander activation” (19–22). This name seemingly refers to
the idea that these are T cells which just happen to be in prox-
imity to inflammatory stimuli that is perhaps intended for other
cognate T cells, thus, assuming that non-cognate stimulation is an
accidental “bystander” to the conventional response. However, it
is equally possible that this “bystander” response is not incidental,
but instead represents an integral functional capacity of T cells
to respond and recognize inflammatory stimuli that are produced
under extreme stress.
The earliest descriptions of bystander activation focus on
cytokine or innate stimuli that drive T cell proliferation in the
absence of antigen (20, 21, 23). These innate stimuli are also
referred to as microbe-associated molecular patterns (MAMPs),
and include toll-like receptor (TLR) and NOD-like receptor (NLR)
ligands among others. However, it should be noted that most of
this early work was completed in viral infection models, focuses
largely on CD8 T cells, and does not differentiate between naïve
and previously activated T cells. Thus, it is difficult to conclude
from these studies whether naïve T cells can actually be primed
by non-cognate interactions, particularly naïve CD4 T cells. Fur-
ther, these data must be interpreted with caution, since cytokine-
induced proliferation may not lead to an effector T cell state, and
especially given the evidence that these same signals can induce
apoptosis (20). Transient expression of the early activation marker
CD69 was observed in naïve CD8 after Type I IFN stimulation,
but neither this activation was not maintained nor was it shown
to induce effector functional capacity (21).
In addition to non-cognate proliferation or upregulation of
activation markers, there is also considerable work describing elic-
itation of effector functions from CD8 T cells by non-cognate
stimuli, which is also confusingly referred to as bystander acti-
vation or stimulation (19, 24, 25). However, it is important to
note that this work generally describes stimulation of previously
activated T cells, or makes no distinction between activated and
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naive T cells, thus, this is not activation in the sense of initial T
cell priming. For clarity, in Figure 3, a non-cognate primary acti-
vation interaction is illustrated as “bystander activation,” while a
non-cognate interaction following (but separate from) a cognate
primary activation interaction is referred to as “non-cognate stim-
ulation.” This stimulation of activated T cells is discussed further
below.
While most of the work described above examines CD8 T cells,
less examination of TCR-independent effector responses exists
specific to CD4 T cells, and most shows that bystander responses
occur only in previously activated or memory CD4 T cells (26–
28). There are, however, limited in vitro data showing that very
high doses of IL-2 can make naïve CD4 T cells responsive to IL-12
or IL-18 without TCR signaling (29). Considering these distinc-
tions, as well as the inability of many of these studies to rule out
innate-like populations that were not yet identified at the time the
studies were conducted, the question of whether naive T cells can
be primed in a non-cognate manner under sufficient inflamma-
tory stimulation, and whether these cells would be functional as
effectors in vivo, lacks a definitive answer. However, non-cognate
stimulation of effector and memory T cells has been shown, and
some of the mechanisms are beginning to be understood.
As described in the previous section, an activated Th1 cell is
primed to produce effector cytokines rapidly. Here, we focus on the
effector cytokine IFN-γ, secreted by both CD8 T cells and Th1 cells.
This priming means that the IFN-γ gene locus is modified to be
open for faster transcription, IFN-γ mRNA has been transcribed
and is ready for rapid translation, and IFN-γ protein has been
translated and awaits the signals necessary for post-transcriptional
modifications and secretion. Despite all of this preparation, Th1
do not constitutively secrete IFN-γ. When they receive antigen-
specific TCR signals, the signaling cascade downstream of the
TCR allows rapid release of the prepared IFN-γ transcripts and
protein from the regulatory mechanisms that otherwise keep this
production in check. However, other signaling pathways can also
stimulate IFN-γ production in activated Th1.
The signals eliciting production of IFN-γ in various cell types
have been studied extensively, and yet the complexity of the reg-
ulation of this cytokine continues to unfold. For example, while
T-bet is considered to be a master transcriptional regulator of IFN-
γ production, in natural killer (NK) cells and CD8 T cells Eomes
is able to make up for the loss of T-bet, while in CD4 T cells T-bet
signaling is required (30). Further, it was shown that the promoter
region of IFN-γ that is utilized after TCR signaling is different than
the promoter region required for IFN-γ production in response
to IL-12 and IL-18 (31). In addition to transcriptional regula-
tion, extensive post-transcriptional regulation of IFN-γ mRNA
has been shown to take place, and varies between naïve, effector,
and memory T cell populations (32).
While some evidence has suggested that an ability for innate
ligands to interact directly with CD4 T cells to stimulate their
proliferation or function (33), it is also likely that innate ligands
can stimulate T cells through a second messenger that would allow
amplification of the signal. Many cells are capable of responding to
TLR or NLR ligands to produce inflammatory cytokines, including
those cytokines known to stimulate IFN-γ production from Th1
cells. Thus, it is easy to imagine a mechanism whereby Th1 cells
respond indirectly to innate stimuli by responding to inflamma-
tion. In fact, this has been shown to occur during viral infections
in response to TLR ligands, and during Salmonella infection in
response to NLR ligands, both in CD8 T cells (24, 25, 34).
Recently, we described a mechanism for innate Th1 stimula-
tion that relies on the convergence of both TLR and NLR signaling
pathways to elicit IL-18 production, which can then be recognized
by activated Th1 to result in IFN-γ secretion. This mechanism
is illustrated in Figure 2. Previous work has typically focused on
very small populations of innately responding T cells, particu-
larly for CD4 cells, consequently supporting the concept of the
“unintended bystander.” However, the small numbers of T cells
that can be seen responding at any given time during the normal
course of infection do not necessarily represent a small subset of
cells capable of innate response. Nor does this imply that innate
stimulation of T cells occurs too infrequently to have a significant
impact. Using Salmonella infection, we showed that Th1 cells in
an infectious model of strong Th1 activation are highly suscep-
tible to innate stimulation, with a large proportion of the Th1
capable of secreting IFN-γ in response to LPS stimulation. Finally,
we demonstrated that mice whose T cells lack the capacity to be
innately stimulated by IL-18 suffer a reduced capacity to clear Sal-
monella infection (35). Together, this suggests that a pathway of
innate T cell response that not only can occur but must also occur
for normal immune function.
INNATE-LIKE T CELLS AND ILCs
While the previous section focused on the non-cognate interac-
tions of conventional αβ T cells, numerous cell types have been
described that have overlapping surface markers, developmental
lineages, transcription factor profiles, or effector functions to con-
ventional T cell subsets, but which respond in a non-conventional
manner (36). These cells are often thought of as innate-like cells
with adaptive-like functions that can provide critical assistance
in the early immune response. Examples include natural killer T
(NKT) cells, mucosal-associated invariant T (MAIT) cells, γδ T
cells, and innate lymphoid cells (ILCs).
Innate lymphoid cells are a rapidly expanding group of cells
defined predominantly by their lack of lymphocyte antigen recep-
tors (TCR or BCR, B cell receptor) or lineage-specific markers
(36). Recently, a uniform nomenclature for ILCs was proposed
that divides the various cells into three main groups. Much like
the CD4 T helper subsets, Group 1 ILCs can be characterized by
the expression of T-bet and IFN-γ, Group 2 express GATA3, and
Group 3 express RORγt and produce IL-17 or IL-22 (37). Most
ILCs require IL-7R signaling and express the surface marker CD90
and the transcription factor ID2, although it has been proposed in
mice that IL-7 may inhibit transition of ILC3 to ILC1 (38). Fur-
ther elaboration will center on the Group 1 ILC subset, given its
similarity to the Th1 subset of CD4 T cells.
Natural killer cells have been included within this nomencla-
ture as a Group 1 ILC, alongside ILC1. While NK cells have been
very well-described as an early source of IFN-γ and TNFα, in addi-
tion to their cytotoxic functions, very little is known about ILC1.
Although there is evidence that they develop from ILC3s after IL-
12 stimulation, it was recently shown that ILC1 can also develop
independently from a common innate lymphoid progenitor (39).
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However, whether they arise separately or as a consequence of
functional plasticity, it remains that there is a group of T-bet+
ILCs, which can respond to IL-12 and IL-18 signals to produce
IFN-γ, but which are not NK cells and do not exhibit cytotoxic-
ity (37, 38). As a whole, the early innate effector responses of the
Group 1 ILCs during intracellular infections play a key role in host
protection, inflammation, and initiation of adaptive responses.
While ILCs lack a TCR, several other cell types express unique
TCRs that allow for a non-conventional response, known col-
lectively as “innate-like T cells” due to their ability to respond
rapidly to innate stimulation. Among these innate-like T cells, one
common method allowing for a non-cognate-antigen response
is an invariant or semi-invariant TCR. While conventional
TCRs undergo recombination activating gene (RAG) dependent
rearrangement of their α and β chains during development in the
thymus to allow for a broader repertoire with improved speci-
ficity, some innate-like cell populations possess TCRs with single
α-chain and restricted β-chain specificities. Particular examples
of cells with these alternative TCRs include invariant NKT cells
(iNKT) and MAIT cells (36).
Natural killer T cells are perhaps the best described of these
innate-like T cell subsets. NKT cells are innate-like T cells in the
sense that they develop in the thymus and express a TCR, but
they also express NK1.1 and several innate activating or inhibitory
receptors typically found on NK cells (40). Two types of NKT cells
exist: NKT I are the well-described, iNKT cells known to respond
to lipids and especially with high affinity to α-galactosylceramide
presented by the MHC-related molecule CD1d, while NKT II are
less studied, to date, but have a diverse TCR repertoire and fail
to respond to α-galactosylceramide (41). While iNKT can be acti-
vated by CD1d presentation of foreign lipid antigens, they may
also be activated by CD1d presentation of lipid self-antigens and
require inflammatory cytokine signals, allowing for more rapid
and innate-like responses (40–42). Further, it was recently shown
that iNKT can be activated in an antigen-independent manner by
cytokine alone during some infections, like Salmonella, but not
others (43).
Another semi-invariant T cell population are the recently
described MAIT cells, characterized by their localization to
mucosal tissue and their recognition of the MHC-related mol-
ecule, MR1, which binds the metabolites of B vitamins gener-
ated by bacteria and fungi (36). MAIT cells develop and are
pre-programed in the thymus, but quickly acquire an activated
phenotype in the periphery. There is now evidence to suggest
that this activation occurs in response to microbiota; in particular,
the observation that germ-free mice have diminished numbers of
MAIT cells, which can be recovered upon monoculture reconsti-
tution with many bacteria or yeast, but not Enterococcus faecalis,
which lacks the riboflavin metabolic pathway. Unlike NKT, they
seem to respond predominantly to TCR ligation and do not require
cytokine stimulation to elicit effector functions, which consist
mostly of IFN-γ and TNFα, although they can also express IL-17
(44, 45).
γδ T cells are a unique exception, in that they possess recom-
bined TCRs, but can respond in a rapid, innate-like manner to
inflammatory cytokines. Thus, these T cells are technically a com-
ponent of the adaptive immune response, but are often discussed
in the context of early innate responses (46). Differentiation pro-
graming of γδ T cells occurs during thymic development, deter-
mining either an IFN-γ, IL-17, or IL-4 producing phenotype (47),
but peripheral activation is still required before effector functions
can be elicited. The relative contributions of TCR, costimulation
and cytokine signals to this activation still seem to be a matter of
some debate, and may be partially dependent on the subset, but
whatever the mechanism these cells respond far more rapidly than
their αβ T cell counterparts (46).
All of these innate-like T cells (iNKT, MAIT, and γδT), although
possessing different TCRs and recognizing different antigen reper-
toires, share some common features. For one thing, in each cell
type the ability to generate or maintain immunological mem-
ory is poorly defined, as are the required signals for survival and
proliferation (36). For both iNKT and γδ T cells functional sub-
sets have now been described analogous to the CD4 T helper
subsets (40, 47), although unlike CD4 T cells these subsets are
pre-determined during development in the thymus. Although
subsets have not yet been defined as such for MAIT cells, and
they typically respond to IL-12 to produce IFN-γ in a T-bet-
dependent manner, they also express RORγt and can express IL-17
and IL-22 under appropriate stimulation. Further, there is now
some evidence for an immunoregulatory function of MAIT cells.
Thus, whether MAIT cells have functional subsets or are simply
functionally promiscuous remains to be determined (44, 45).
In further similarity, each is described as “innate-like” due to
an ability to rapidly respond to innate stimulation – that is, they
respond to the inflammatory cytokines that result from innate
stimuli. However, for each cell subset the specific requirements
of initial priming, and in particular whether this priming can
occur without any peripheral TCR stimulation, is still a matter
of debate within their respective fields. While earlier literature
suggested that these cells respond rapidly because they are able
to respond to cytokine alone, other work shows that these cells
require TCR interactions (48), and for iNKT at least this require-
ment can be met by self-antigens under inflammatory conditions
to allow more rapid responses (40–42). More recent evidence
suggests that these requirements may differ under varying cir-
cumstances (43). Herein, we make an argument that conventional
αβ T cells can also respond rapidly to inflammatory cytokines in
an innate-like manner once they have been primed. The paral-
lels between these responses and their mechanisms suggest that a
conservation of these stimulatory mechanisms between conven-
tional and innate-like T cells, and highlight the need for a better
understanding of the activation requirements of non-conventional
T cells.
A COMPLICATED RELATIONSHIP: THE DYNAMIC
INTERACTIONS OF SALMONELLA AND Th1 CELLS
SALMONELLA: A PERSISTENT GLOBAL CHALLENGE
While many bacteria live and replicate extracellularly, entering the
host cell only when engulfed and destroyed by phagocytes, some
bacteria have adapted unique survival strategies to allow a pro-
tected life cycle within host cells. Some of these bacteria are obligate
intracellular pathogens, like Chlamydia, that cannot replicate out-
side of the cell, but many intracellular bacteria are capable of occu-
pying either space. The immune system has, in turn, developed a
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number of ways to recognize pathogens within cells, pathways
which the pathogen actively attempts to thwart (49).
In this review, we focus on Salmonella, a Gram-negative enteric
pathogen that resides predominantly within the phagosomes of
macrophages located in the spleen, liver, and bone marrow.
In human beings, there are two forms of systemic salmonel-
loses: typhoid fever and non-typhoidal salmonellosis, or NTS.
Typhoid and paratyphoid fevers are caused by the human-specific
pathogens Salmonella enterica serovar Typhi and Paratyphi, still
occur endemically in developing countries, and can cause severe
systemic disease even in healthy individuals. Estimates range as
high as 27 million annual infections with either Typhi or the clin-
ically indistinguishable Paratyphi. In contrast, NTS occurs only
in immunocompromised individuals, but can originate from any
of the >2000 Salmonella serovars capable of causing foodborne
illness in human beings and harbored in a wide variety of animal
reservoirs (50). Thus, both systemic infections remain a source of
concern for public health officials worldwide.
Although antibiotics effective against Salmonella are available,
the options are relatively limited for intracellular pathogens as
compared to more accessible extracellular pathogens. Addition-
ally, among those antibiotics currently available, there is a grow-
ing incidence of drug resistance, including multi-drug resistance
to the first-line treatments, and resistance to the now standard
fluoroquinolones. Further, decreased susceptibility to the fluo-
roquinolone ciprofloxacin has been associated in enteric fever
patients with prolonged fever and increased rates of treatment fail-
ure (51). Finally, an analysis of the Salmonella metabolic pathways
has suggested that most of the major or non-redundant pathways
have already been targeted or considered for drug inhibition, sug-
gesting that a limitation to prospective future development of new
antibiotic treatments (52). Together, these studies emphasize the
need for alternative treatment options and for improved vaccina-
tion strategies that could lessen the need for, and consequently the
selective pressure upon, traditional antibiotic therapy.
Currently, two vaccinations are commercially available in the
U.S. for travelers to typhoid endemic countries. One is a Vi capsu-
lar polysaccharide (ViCPS) vaccine administered intramuscularly
as one dose at least 1 week prior to exposure. The second is an
oral, attenuated Ty21a vaccine available under several formula-
tions, typically administered every other day as three separate doses
2 weeks prior to exposure. Both vaccinations suffer from limita-
tions that impair their practicality in typhoid endemic regions,
not the least of which is the need for regular re-vaccination, and
the low-reported efficacy at 3 years of 51–55% (53). The ViCPS
vaccine is approved in children over the age of 2 years old, and the
oral vaccine for children over the age of 5 years, while repeated
exposure before the age of 5 in endemic areas has been shown.
This suggests that the vaccines available miss a key population.
In addition, while evidence suggests that Ty21a may be cross-
protective for paratyphoid, the ViCPS vaccine targets an antigen
that does not exist in Paratyphi and even some strains of Typhi
(51, 54). Further, because the oral vaccine is a live, attenuated Sal-
monella strain, it is not suitable for use in immune-compromised
patients, posing a challenge to widespread use in areas co-endemic
for HIV. Thus, currently available vaccination strategies are not
adequate to allow control of systemic typhoidal disease (53).
Whether currently available vaccines mediate any protection to
non-typhoidal systemic diseases has not been thoroughly char-
acterized. These data emphasize a need to better understand
the immune response during systemic Salmonella infections, to
inform better vaccine design.
IMPORTANCE OF Th1 CELLS AND IFN-γ IN INTRACELLULAR INFECTIONS
As mentioned earlier, some bacteria and other pathogens have
developed the capacity to reside within cells and effectively hide
from extracellular immune recognition. Often, these pathogens
enter the cells initially using the cells’ own phagocytic capacity,
but then are able to escape phagolysosomal degradation or escape
the phagosome entirely, by a wide range of different mechanisms
(49, 55). Given this unique lifestyle, intracellular pathogens require
a special type of immune response designed to recognize infected
phagocytes and mediate either killing of the infected cell or internal
pathogen killing mechanisms. CD8 T cells have cell-specific cyto-
toxic capacity, allowing directed killing of infected cells, while both
CD8 and CD4 T cells can secrete pro-inflammatory cytokines that
activate phagocytes to initiate internal mechanisms of pathogen
destruction.
CD8 T cells have multiple cytolytic capacities initiated by TCR
interactions, including release of secretory granules and death
receptor-mediated apoptosis. However, while these responses have
a critical role in anti-viral defenses, their role against other intra-
cellular pathogens is limited (56). Of more importance to intra-
cellular bacterial infections, CD8 can produce pro-inflammatory
cytokines such as IFN-γ, which activates macrophages to undergo
changes that alter the intracellular environment to become less
hospitable to the invading pathogen. While CD8 T cells respond
to MHC-I complexes that mostly present antigen processed from
the cytosol of nearly all cell types, CD4 T cells respond to MHC-II
presented antigen on special APCs derived from the endocytic
pathway. This allows CD4 T cells to recognize antigens from
pathogens hiding inside of cells within endosomes, as well as anti-
gens taken up from outside of the cell (57). Reliance on different
antigen processing pathways and consequent MHC presentation
allows a partial division of labor between the CD8 and CD4 T cells,
although they have retained some redundancy in critical functions,
such as production of IFN-γ.
Among the various CD4 T cell subsets, the CD4 Th1 cells
provide the primary response to intracellular pathogens. As men-
tioned earlier, after CD4 T cells are activated they receive a differ-
entiation signal that determines their cytokine profile. In Th1 cells,
IL-12 upregulates the transcription factor T-bet, which is required
by CD4 T cells for IFN-γproduction (58). Once activated,Th1 cells
are programed to secrete pro-inflammatory cytokines that include
IFN-γ, TNFα, and IL-2 upon re-stimulation. In contrast, CD8 T
cell priming is not usually thought of in terms of differentiation
of particular subsets with distinct functions, although functional
subsets have been described. Termed Tc1, Tc2, and Tc17 in ref-
erence to their Th counterparts, these cells are found in relatively
low-frequency under normal circumstances, and the mechanisms
driving the development of these alternative CD8 T cells remain
poorly understood (58). Signal 3 was initially identified in CD4
and CD8 T cells simply as the inflammatory cytokine(s) required
to induce proliferation and differentiation to effector capacity (59).
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Type I interferons and IL-12 have both extensively been shown to
result in the survival, expansion, and differentiation of CD8 T cells,
and are critical for the conventionally described CD8 T cell effec-
tor responses, including cytolytic activity and IFN-γ production
(59–62).
Additional differences between CD4 and CD8 T cell activation
include, but are not limited to a shorter required duration of anti-
genic stimulation in CD8 T cells (63–65), different transcriptional
regulation, including partial redundancy for the transcription fac-
tors T-bet and Eomes in IFN-γ production in CD8, but not CD4
(30), and differences in cellular trafficking and antigen surveil-
lance (66). Further, evidence suggests that CD4 T cells can help to
initiate CD8 T cell priming (67, 68), and may be required for opti-
mal CD8 memory formation, a regulatory interaction that argues
against mechanistic redundancy in the activation process. Thus,
while T cells have evolved to share many similar pathways, CD4
and CD8 T cells are distinct cell types with different functions and
rules to govern them. When studying T cell functions it is critical
to keep these differences in mind and to choose a model system
capable of demonstrating the full potential of the cell of interest.
Accordingly, the strong requirement for Th1 cell functions in Sal-
monella infections makes this model system ideal for study of Th1
responses (9–11).
The cytokine IFN-γ is especially important during intra-
cellular infection because of its critical capacity to activate
macrophages to become M1, or classically activated, macrophages.
M1 macrophages modify their internal environment to become as
inhospitable as possible, including production of anti-microbial
compounds like reactive oxygen and nitrogen species, as well
as themselves secreting pro-inflammatory cytokines (69). The
importance of IFN-γ-mediated macrophage activation is high-
lighted by the effects, resulting from the loss of IFN-γ or IFN-
γ-inducing cytokines and transcription factors (11, 70, 71). In
both mice and human beings, loss of IFN-γ results in an inability
to effectively clear intracellular pathogens (72). Further, in human
beings with chronic granulomatous disease or mycobacterial gran-
ulomas, IFN-γ is an effective, albeit toxic, therapeutic (73–75).
Combined, these studies clearly demonstrate the requirement of
IFN-γ for effective clearance of intracellular pathogens.
PLAYING HARD TO GET: HOW SALMONELLA SUBVERTS THE Th1 CELL
RESPONSE
The critical role of Th1 cells in Salmonella clearance makes them
an obvious target for immune evasion strategies. While there is
extensive information available on the ways that Salmonella has
found to manipulate the system (76, 77), we focus here particu-
larly on immune evasion strategies that impair the ability for T
cells to recognize their specific antigen. Three of the ways that
Salmonella have developed to achieve this include downregula-
tion of antigens that may be recognized by T cells, effects on
TCR expression or function, and impairment of MHC process-
ing or presentation of peptides (Figure 4A). The active avoidance
of TCR recognition employed by Salmonella provides one possi-
ble explanation for the maintenance of a TCR-independent T cell
stimulatory pathway.
When Salmonella change environments, from contaminated
source to intestine to myeloid cells, their expression of antigens
recognized by T cells rapidly changes (8). In addition to responding
to a change in needs, this antigenic shift acts as a highly effective
immune evasion strategy, resulting in the activation and expan-
sion of large numbers of T cells that specifically recognize antigens
that will not be present at the site of infection. The T cell response
to FliC was shown to be inefficient at resolving infection over a
decade ago, and both SipC and FliC elicit an early T cell response
despite rapid downregulation of these antigens by Salmonella (7,
78, 79). Thus, much of the early T cell response may develop to
antigens that are not available at the site of infection, preventing
cognate activation for these cells.
Additionally, a number of mechanisms have been demonstrated
by which Salmonella causes downregulation of the TCR on T cells
(80). Flagellin stimulation has been shown to result in upregu-
lation of SOCS1, which impairs TCR expression in T cells (81).
Further, direct contact of Salmonella with T cells results in secre-
tion of the enzyme l-asparaginase II by Salmonella, which breaks
down l-asparagine and consequently impairs T cell blastogenesis,
proliferation, and cytokine secretion by downregulating the TCR
β chain (82, 83). While these mechanisms may impair the initial
priming of T cells, the requirement for direct contact between
T cells and bacteria in some of these studies suggests that the
importance of these evasion techniques at sites of infection.
Finally, many strategies have been demonstrated by which Sal-
monella is able to inhibit either the processing of antigens into pep-
tides or the presentation of these antigenic peptides on the surface
of APCs within the MHCs (80, 84). Nearly 20 years ago, the two-
component regulatory system member PhoP was shown to impair
processing and presentation of antigens in macrophages (85). Fur-
ther, numerous Salmonella pathogenicity island-2 (SPI-2) effector
proteins have been implicated in impaired MHC function, includ-
ing impaired loading of peptides onto MHC, prevention of lyso-
somal degradation that results in decreased peptide availability,
and polyubiquitination of MHC that results in degradation rather
than surface expression (86–89). Each of these interactions targets
a step in the antigen presentation pathway that ultimately results
in an impaired ability for infected cells to signal to T cells.
Given the hindrance of cognate T cell stimulation, the ability
for T cells to be stimulated by non-cognate interactions as well
could play an important role in Salmonella clearance. Salmonella
induces a number of different non-cognate responses via PRRs, as
outlined in Figure 4B. These include well-characterized TLR and
NLR interactions, as well as other, less well-defined PRR inter-
actions (90). Recognition of these various non-cognate ligands
results in inflammation, including production of inflammatory
cytokines that can stimulate T cells. This indirect stimulation
of T cells in response to non-cognate Salmonella products pro-
vides a complementary mechanism for T cell stimulation at sites
of infection with a broad array of conserved triggers. While the
multitude of Th1 evasive mechanisms accentuates the need for
innate signaling pathways in the elicitation of Th1 cell functions,
it is important to note that innate immune pathways are not
exempt from evasion strategies (91, 92). Thus, in order to pro-
vide T cells the best chance to encounter and respond to signs
of infection, redundant mechanisms for stimulation that rely
on either cognate antigen or MAMP-driven inflammation have
developed.
Frontiers in Immunology | Microbial Immunology December 2014 | Volume 5 | Article 621 | 8
O’Donnell and McSorley Non-cognate CD4 response in Salmonella
FIGURE 4 | Direct and indirect stimulation ofTh1 by Salmonella. (A)
Salmonella has developed multiple mechanisms to inhibit direct Th1
stimulation by cognate antigen recognition. Conventionally,
Salmonella-specific antigens would be processed and presented by APCs on
MHC-II to the TCR of Th1 cells to elicit IFN-γ at sites of infection. However,
Salmonella has developed a wide array of strategies to limit this interaction.
This includes (1) downregulation of antigens that were expressed upon entry
into the host that T cells may have been primed to recognize, (2) mechanisms
designed to impair processing and presentation of antigen by APCs, including
downregulation of MHC itself, and (3) effects upon the expression or function
of the TCR. These strategies aim to block cognate antigen recognition each
step of the way, making additional non-cognate mechanisms for T cell
stimulation crucial. (B) Many innate immune recognition pathways respond to
Salmonella, and these elicit cytokines that allow Th1 cells to be stimulated by
non-cognate pathogen products indirectly at sites of infection. (1) Several
TLRs recognize conserved patterns present in Salmonella, including TLR-4
recognition of LPS, TLR-5 recognition of flagellin, and other TLRs that
recognize bacterial nucleic acids from within the endolysosome. (2) The role
of NLRs and the inflammasomes have also been well-demonstrated for
Salmonella. While NLRC4 is known to recognize both flagellin and T3SS (Type
3 secretion system) rod proteins, the exact ligand recognized by NLRP3 from
Salmonella is unknown. NLRP3 recognizes a number of nuclear components,
which act as danger signals when present in the cytosol, but other ligands
have been proposed. (3) Although less well-characterized, other classes of
PRRs have the potential to recognize Salmonella, including the various
cytosolic nucleic acid sensing receptors.
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DISCUSSION
Herein, we have discussed a number of advantages to studying
Th1 cell responses in a Salmonella model. The strong understand-
ing of both CD4 T cell and innate immune pathways during the
response to Salmonella infection provides a strong foundation to
further explore the potential interaction between these pathways.
Moreover, the tools for these studies are readily available in such
a well-studied and easily manipulated model pathogen. Together,
these factors make Salmonella an ideal model pathogen for the
study of non-cognate Th1 cell responses.
Furthermore, we highlight a number of questions that remain
to be answered in the study of non-cognate T cell interactions. One
such question: what is the fate of Th1 cells after non-cognate stim-
ulation? While it is possible that cells undergo the same response
and fate following either cognate or non-cognate secondary inter-
actions, there is still limited understanding of the effect of multiple
stimulatory interactions with T cells. It is possible that the height-
ened effector response that occurs after re-stimulation impacts the
fate decisions of effector T cells. It is also possible that the combi-
nation of cognate activation and non-cognate stimulation could
regulate cell fate differently than solely cognate interactions. If that
is the case, non-cognate stimulation could result in apoptosis and
the subsequent loss of these cells, or it could act as a signal for a
cell that should transition to memory during contraction. Within
the memory pool, there may be a subtle difference between cells
that did or did not receive non-cognate stimulation during their
effector phase. Further work is required to determine what the
impact of this response pathway is on T cell fate decisions.
Additionally, more work is necessary to clarify the require-
ments and role of non-cognate interactions of memory CD4 T
cells. Our data have shown that the response of memory T cells
to LPS alone after Salmonella clearance is much lower than the
response observed during infection (35). However, it is not yet
clear why so few memory T cells were able to respond. Could they
require cognate re-activation first, and if so, why? Does the active
infection contribute something necessary for non-cognate T cell
stimulation, such as inflammasome activation or an additional
cytokine? If something is missing, why are any memory T cells
able to respond to the stimulation? Is there something different
about these memory cells that retain innate stimulatory capacity?
Understanding the memory response is critical to understanding
the role of non-cognate stimulation, in particular, when trying to
apply these findings to the improvement of vaccine strategies or
to understanding a possible role in autoimmune disease.
Finally, while much of the early work in describing cognate
T cell interactions was done in vitro, recent advances in the
capacity of live in vivo imaging technologies have allowed for real-
time observations of these complex interactions. This system is
advantageous because it allows for individual cell tracking and a
chronological history of a specific cell under natural conditions.
For example, during the activation process an individual T cell
may interact with many separate DCs, and these interactions have
a cumulative effect upon T cell function (63). Further, it allows
exploration of such brief conversations as occur, for instance, at
the kinapse, which are otherwise difficult to capture due to their
transience (93). Unfortunately, there are currently technical limi-
tations that could make visualizing T cell responses to Salmonella
difficult. As the technology continues to improve, studies such as
these will open the door for a new understanding of the dynamic
complexity of T cell interactions within the contexts of time and
space that have, until now, proven particularly challenging for
immunologists (94). Similarly, it may soon be possible to watch
cognate and non-cognate T cell interactions as they occur to begin
to answer questions about non-cognate Th1 stimulation such as
those posed here.
As the mechanisms underlying non-cognate Th1 stimulation
become clearer it may also become possible to define the rela-
tive contributions of cognate and non-cognate T cell interactions
at various stages in the Th1 response. For example, in Section
“Bystander Activation and Non-Cognate Stimulation,” we discuss
recent evidence that Th1 cells require IL-18 receptor signaling in
order to respond to non-cognate signals but not for initial TCR-
dependent activation. These differential pathways provide one
possible tool for separating cognate and non-cognate response
roles. To deeply explore these responses and their outcomes, a
system in which each pathway could be selectively and tran-
siently inhibited would be ideal. Such studies could be critical
to understanding the role of infection and inflammation in T cell
responses.
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